APCCC 2024: Who Should Undergo Germline Testing?
APCCC 2024, advanced prostate cancer, germline testing for prostate cancer, metastatic castrate-resistant prostate cancer (mCRPC), germline mutations, BRCA1, BRCA2, ATM, PALB2, CHECK2, HOXB13, MLH1, MSH2, MSH6, PMS2.